Drug Treatment Information You Can Understand

Heard about a new cancer treatment or drug? New technology and research are continuing to offer us new ways to combat cancer.

As the FDA approves more new cancer treatments and drugs, we’ll do our best to help educate and inform cancer patients on these new treatments. Each video provides an overview of how the treatment works, which types of cancer the treatment targets and what types of side effects may occur from a particular treatment.

It’s an exciting time in cancer research and we will do our part to offer updates and reviews on these new ways to take on cancer.

New Cancer Drugs and Treatments Library

How Darzalex Treats Multiple Myeloma

Darzalex (Daratumumab) is a promising new immunotherapy cancer treatment for patients with multiple myeloma

Xgeva (Denosumab) is atargeted cancer treatment that is used to help prevent bone fractures and other skeletal conditions that may occur where the cancer has spread to the bones

Cancer can cloak itself so the immune system does not detect it. Opdivo (nivolumab) is an antibody that binds to T cells so the immune system can find them.

20% of breast cancer cases and 10-20% of stomach cancers are HER2-positive. Oncologist Stephen Lemon MD describes how this cancer treatment works and it’s side effects.

This targeted therapy has shown in studies to help patients live without cancer spreading and live longer compared to patients not taking the drug.

Recently approved by the FDA, Lynparza (olaparib) is a targeted cancer treatment for certain types of advanced ovarian cancers.

Ibrance (palbociclib) is offering hope as a new hormone based cancer treatment for advanced breast cancer patients who meet a specific criteria.

Keytruda (pembrolizumab) is a new cancer drug that treats advanced melanoma by using the patient’s immune system to attack cancer cells.

Recently approved cancer drug Xofigo (radium-223 dichloride) offers a new treatment for patients with late stage prostate cancer.

Perjeta (pertuzumba) is helping to extend the lives of patients with an aggressive type of breast cancer referred to as HER2-positive breast cancer.

Kadcyla (T-DM1) is a targeted breast cancer drug treatment for women with stage 3 or stage 4 HER2-positive breast cancer.

Afatinib (Gilotrif) is a new FDA approved targeted cancer therapy for certain types of lung cancer, such as metastatic non-small cell lung cancer.

Avastin (bevacizumab) is a targeted therapy for various metastatic cancers, including colorectal and lung cancer.

Dr. Stephen Lemon explains clinical trials and how they work, including trial phases, and how cancer patients may choose to volunteer, based upon their eligibility criteria.

What is targeted cancer therapy and how does it compare to standard chemotherapy? This video compares these two forms of cancer treatment.

Oncology Associates

Provides world class cancer care to patients in Omaha and throughout Nebraska, with clinic in Blair.

Let’s Get Started!

Drug Treatment Information You Can Understand

New Cancer Drugs and Treatments Library

How Darzalex Treats Multiple Myeloma

How Xgeva Treats Bone Metastases

Opdivo Immunotherapy Cancer Treatment

Herceptin for Breast and Stomach Cancer

Cancer Treatment Imbruvica

About Ovarian Cancer Treatment Lynparza

Breast Cancer Treatment Ibrance

Melanoma Cancer Drug Keytruda

Prostate Cancer Treatment Xofigo

Her2 Positive Breast Cancer Drug Perjeta

Breast Cancer Drug Kadcyla

Lung Cancer Drug Gilotrif

How Avastin Treats Advanced Cancer

How Do Cancer Clinical Trials Work

How Does Targeted Therapy Work?

Oncology Associates